CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PE9ZJK4

Market Closed - Deutsche Boerse AG 01:10:14 01/06/2024 am IST
110.5 EUR -0.14% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-1.14%
1 month-1.14%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/24/31 110.5 -0.14%
30/24/30 110.6 -0.30%
29/24/29 110.9 +0.53%
28/24/28 110.4 -0.01%
27/24/27 110.4 -0.05%

Delayed Quote Deutsche Boerse AG

Last update May 01, 2024 at 01:10 am IST

More quotes

Static data

Product typeCertificati Bonus e Protezione parz.
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE9ZJK
ISINDE000PE9ZJK4
Date issued 28/02/2023
Strike 120 $
Maturity 21/06/2024 (20 Days)
Parity 1 : 1
Emission price 93.34
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 111.9
Lowest since issue 90.23
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus